RxDoctor Payments Data

Cheree Raimey, APRN

Family · Liberty Township, OHNPI 1720866114

Payments from drug & device makers

$742in general payments, 2019–2025

Across 33 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$269
  • Otsuka America Pharmaceutical, Inc.$120
  • Novo Nordisk$74
  • AstraZeneca$67
  • Exact Sciences$53
  • Pfizer$37
  • plus $121 from 6 others

What the payments were for

  • Food & beverage$742100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$742 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$3,073
Medicare patients
29
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$26,346
JardianceEmpagliflozin12$19,426
MounjaroTirzepatide11$11,702
Atorvastatin Calcium171$1,080
Levothyroxine Sodium108$935
Omeprazole51$700
Gabapentin37$678
Pantoprazole Sodium41$571
Lisinopril70$546
SynthroidLevothyroxine Sodium12$504
Amlodipine Besylate77$468
Metoprolol Succinate38$456
Albuterol Sulfate HfaAlbuterol Sulfate18$434
Venlafaxine Hcl ErVenlafaxine Hcl11$353
Escitalopram Oxalate23$329

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$26,34623 claims
Boehringer IngelheimJardiance$29$19,42612 claims
Lilly USA, LLCMounjaro$18$11,70211 claims
AbbVieSynthroid$269$50412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Liberty Township

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →